US announces prices in Medicare drug negotiations
Tweet
Share
E-mail
FILE PHOTO: U.S. dollar banknote and medicines are seen in this illustration taken, June 27, 2024. REUTERS/Dado Ruvic/Illustration/File Photo
(Reuters) - The U.S. announced the final prices of its first ever negotiation over prescription drugs on Thursday, with Merck's diabetes drug Januvia seeing the steepest percentage cut at 79%.
The government negotiated prices for 10 of the most expensive medicines for its Medicare program serving Americans age 65 or older and the disabled, which covers 66 million people.
Those drugs include top-selling blood thinner Eliquis from Bristol Myers Squibb and Pfizer and Merck & Co's Januvia.
(Reporting by Ahmed Aboulenein in Washington, Deena Beasley in Los Angeles and Manas Mishra in Bengaluru; editing by Caroline Humer and Josie Kao)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Investors pull money from equity funds as rising oil prices fuel inflation fears
- Wall St futures recover as oil slides ahead of inflation test
- Investors brace for possible rate hike at uncertain Fed meeting
Create E-mail Alert Related Categories
General News, ReutersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
